Prelude Therapeutics Stock Forecast

Sell candidate since May 26, 2026 Loss -10.51%

The Prelude Therapeutics Incorporated stock price gained 4.57% on the last trading day (Wednesday, 3rd Jun 2026), rising from $3.50 to $3.66. During the last trading day the stock fluctuated 9.41% from a day low at $3.40 to a day high of $3.72. The price has fallen in 7 of the last 10 days and is down by -14.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 thousand more shares were traded than the day before. In total, 375 thousand shares were bought and sold for approximately $1.37 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.52 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 28.36% during the next 3 months and, with a 90% probability hold a price between $4.52 and $8.04 at the end of this 3-month period.

PRLD Signals & Forecast

Prelude Therapeutics Incorporated has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Prelude Therapeutics Incorporated stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.87 and $4.46. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 15, 2026, and so far it has fallen -33.70%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Prelude Therapeutics Incorporated stock

Prelude Therapeutics Incorporated finds support from accumulated volume at $3.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.320 between high and low, or 9.41%. For the last week, the stock has had daily average volatility of 7.48%.

Prelude Therapeutics Incorporated is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRLD) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Prelude Therapeutics Incorporated to open at $3.59, and during the day (based on 14 day Average True Range), to move between $3.46 and $3.86, which gives a possible trading interval of +/-$0.397 (+/-11.47%) up or down from last closing price. If Prelude Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 11.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.60 (1.64%) than the resistance at $4.27 (16.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Prelude Therapeutics Incorporated stock A Buy?

The Prelude Therapeutics Incorporated stock holds several negative signals and despite the positive trend, we believe Prelude Therapeutics Incorporated will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.396 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $3.59 ( 1.82%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk